Sort
25,944 grants matching “neurodegeneration”
Yale Cellular Neuroscience, Neurodegeneration and Repair (CNNR) Program
$762,000Stephen M Strittmatter · Yale University · P30 · FY2010 · NS
REDUCED NEUROPLASTICITY PRECEDES NEURODEGENERATION IN PARKINSON'S DISEASE PATIENT-SPECIFIC MIDBRAIN ORGANOIDS
$761,794Universite Du Luxembourg Etabl. Public · · FY2018 · Defense Health Agency
Sphingolipid Biology of Neurodegeneration
$761,760Richard Proia · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK
HIV-induced neuroinflammation associated with opiod abuse and tobacco smoke
$761,723Thomas J Rogers · Temple Univ Of The Commonwealth · R01 · FY2017 · DA
Alzheimer's Abeta, Tau, Apolipoproteins and Blood-brain barrier
$761,538Hussein N Yassine · University Of Southern California · R01 · FY2024 · NS
Pathophysiological Study of Mesolimbic and Mesocortical Dopaminergic Neurons in Parkinson's Disease
$761,265Huaibin Cai · National Institute On Aging · ZIA · FY2021 · AG
Cellular Viscosity as a Marker for Alzheimerâs Disease Pathology: A Combined Multiparametric MR Spectroscopy and PET Study
$761,259Ivan Ivanov Kirov · New York University School Of Medicine · R01 · FY2025 · AG
White matter degeneration: biomarkers in preclinical Alzheimer's Disease
$761,218Barbara Brigitta Bendlin · University Of Wisconsin-Madison · R01 · FY2021 · AG
Discovery of Selective Inhibitors for the EphA4 Kinase
$760,964Eduard A. Sergienko · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2023 · AG
Glial control of neuron development and function
$760,908Shai Shaham · Rockefeller University · R35 · FY2018 · NS
Regulation of entorhinal cortex layer II vulnerability by a cell-type specific miRNA
$760,803Jean-Pierre Roussarie · Boston University Medical Campus · R01 · FY2024 · AG
Deciphering the Glycan Code in Human Alzheimer's Disease Brain
$760,730Ramon C. Sun · University Of Florida · R01 · FY2023 · AG
Explore roles of HSV-1 in Alzheimer's disease using mouse models
$760,469Pinghui Feng · University Of Southern California · R01 · FY2025 · AG
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma
$760,417Dong Feng Chen · Schepens Eye Research Institute · R01 · FY2021 · EY
The Role of Impaired Neurobehavioral Alertness in Cognitive Decline and Alzheimerâs Disease Pathology
$760,415David T Plante · University Of Wisconsin-Madison · R01 · FY2024 · AG
Development of PET Tracer for Imaging Brain Inflammation
$760,405Vijay Sharma · Washington University · R01 · FY2025 · AG
Attentional Resilience in Older Adults
$760,360Leah Acker · Duke University · R01 · FY2025 · AG
Roles of Cdk5 in neurodevelopment and neurodegeneration
$760,318Edward Giniger · National Institute Of Neurological Disorders And Stroke · ZIA · FY2013 · NS
Disease Mechanism and Therapy in TDP-43 Proteinopathies and Dementias
$760,099Don W. Cleveland · University Of California, San Diego · R01 · FY2025 · NS
White matter degeneration: biomarkers in preclinical Alzheimer's Disease
$760,068Barbara Brigitta Bendlin · University Of Wisconsin-Madison · R01 · FY2022 · AG
Development of an information-rich assay for C9ORF72 as a test for ALS and FTD
$759,812Sarah Nicole Statt · Asuragen, Inc. · R44 · FY2017 · NS
Persistent HIV-1 expression and microglia dysfunction
$759,381Andrew J Henderson · Boston Medical Center · R01 · FY2021 · DA
CSF Clearance in Sporadic Alzheimer's Disease
$759,366Yi Li · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · AG
Lactate as a regulator of Alzheimer's pathology
$759,352Shannon L Macauley-Rambach · University Of Kentucky · R01 · FY2025 · AG
Probing Alzheimer synaptopathy using genetically engineered human neurons derived from iPS cells
$759,298Marius Wernig · Stanford University · R01 · FY2025 · AG